Sales revenue in constant currencies down 16.4 percent, excluding Covid-19-related business down slightly above 10 percent; underlying EBITDA marg...
ERS Genomics Limited ('ERS') completes licensing agreement with Syngene International, India's leading Contract Research, Development and Manufacturing Org...
Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein Biomarker Discovery and Providing Strong Synergy Opportuniti...
Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation (NYSE:DHR), ...
Committed to sustainable growth and long-term planning Dedicated to making investments to support increased customer demand Maintain efficiency a...
“This collaboration between Revvity and Element Biosciences seeks to elevate the overall customer experience by providing compelling application-spec...
Charles River Laboratories International, Inc. announced the ability to conduct preclinical cancer research using ITCC-P4’s well-characterized collec...
Building on the award-winning Allia platform for image guided therapies, the new Allia IGS Pulse was designed to improve workflow for the diagnosis and t...
Receipt of the order is an important next step in evaluating divestiture options for GRAIL. Illumina is committed to resolving all issues regarding GRAIL i...
Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) fo...
AstraZeneca announced the eight winners of the 2023 R&D Postdoctoral Challenge. and agreed to fund them to hold a postdoctoral position in one of...
SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic tech...
Danaher's new motto is "Accelerating the Power of Science and Technology to Improve Human Health." The organization's renewed focus is on driving innovatio...
A global licensing agreement has been signed for the development and commercialization of SOFIE’s two investigational Gallium-68 and Fluorine-18 Fi...
© 2025 Biopharma Boardroom. All Rights Reserved.
